Novartis AG - Company Profile
Powered by 
All the sales intelligence you need on Novartis AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Novartis AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Novartis AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View more- Top 10 Pharmaceutical Companies in Europe in 2022 by Market Capitalization
- Top 10 Big Biopharma Companies (Large Pharma & Large Biotech) in Europe in 2021 by Revenues
- Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure
- Top 10 Pharmaceutical Companies in the World in 2022 by Market Capitalization
View up-to-date information on Novartis AG’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 30 Nov 2023 | SEQENS Acquires CELLforCURE from Novartis | Acquisition |
SEQENS
|
CELLforCURE
|
| 13 Nov 2023 | Novartis Pharma to Enter into Licensing Agreement with Legend Biotech | Licensing Agreement |
Novartis Pharma AG
|
Legend Biotech Ireland Ltd
|
| 06 Nov 2023 | Novartis Enters into Licensing Agreement with Chong Kun Dang Pharma (CKD Pharm) | Licensing Agreement |
Novartis AG
|
Chong Kun Dang Pharmaceutical Corp. |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer